Home – Biotech Industry Examiner

€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough

Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy

Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity

Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market

Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan.

A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads

From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough

Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy

Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity

Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market

Researchers Awarded $15 Million to Study Impact of Inflammation on Heart and Brain

Researchers Awarded $15 Million to Study Impact of Inflammation on Heart and Brain

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments

Forbion-Backed VectorY Therapeutics Raises $138M for ALS and Neurodegenerative Disease Research

Marea Biotech Secures $190 Million for Heart Disease Research

Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies

Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market

Marea Biotech Secures $190 Million for Heart Disease Research

Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities

STORIES WE THINK YOU MIGHT LIKE

Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows

Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion

Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion

Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development

MOST POPULAR

Light-Based Microcapillary Monitoring Expands Precision in Biotechnology

Light-Based Microcapillary Monitoring Expands Precision in Biotechnology

Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion

Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion

Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery

Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery

Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate

Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate

Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies

Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies

Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results

Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results

Aging Science

Impact of Space Travel on Immune Function and Potential Countermeasures

Timeline Concludes Major Immune Aging Study with Promising Results

New Study Highlights the Impact of Early-Life Tobacco Exposure on Accelerated Aging

Epigenetic Stability Linked to Lifespan in Mammals, Research Show

Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In

AI in Biotech

Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery

Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies

How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria

Biotech Stocks

Alumis IPO Priced at $16, Targets $210M Funding

Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion

Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate

CRISPR

CRISPR-Cas9 Enhances Rice Yields Without Introducing Foreign DNA

Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market

Food Biotech

Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste

Funding

Novo Holdings Leads $100 Million Series C Financing for Asceneuron

Marea Biotech Secures $190 Million for Heart Disease Research

UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies

Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding

German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies

Genomics

AstraZeneca Completes Equity Investment in Cellectis to Enhance Gene Therapy Development

Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development

Epigenetic Stability Linked to Lifespan in Mammals, Research Show

Insights

Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy

Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up

From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle

A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads

Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan.

Longevity

Manulife and World Economic Forum Launch Longevity Innovation Challenge

The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price

Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough

M&A & Partnerships

Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide

Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities

Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development

Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion

Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion

Neuroscience

Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery

€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?

News

Novo Holdings Leads $100 Million Series C Financing for Asceneuron

AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments

EU Sets New Goals for Advancing Biotechnology and Biomanufacturing

Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis

Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials